StockData

RxSight vs Sight Sciences

RXST and SGHT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RXST and SGHT compare

Sight Sciences is the larger company, worth 2.9 times as much as RxSight ($578M against $201M).

Sight Sciences grew revenue faster over the last twelve months (9.3% versus −13.2% for RxSight).

Sight Sciences keeps more of each dollar of sales as profit, with a net margin of −35.7% compared with −36.8% at RxSight.

RxSight scores higher on the StockData Score (10 against 4 for Sight Sciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRXSTSGHT
Size and price
Market cap$201M$578M
Share price$4.83$10.49
Change, 1 year−50.4%47.5%
Change, 5 years−61.0%−45.0%
Beta (5Y)1.332.87
Employees461186
StockData Score
Total score10 (better)4
Valuation score3 (better)0
Growth score22
Performance score11
Health score4 (better)1
Dividend score00
Valuation
P/S1.6× (better)6.9×
P/B0.8× (better)10.9×
FCF yield−13.5%−4.0% (better)
Fair value$20.39$3.97
Margin of safety76.3% (better)−164%
Growth
Revenue growth (TTM)−13.2%9.3% (better)
Revenue growth, 5Y average55.7% (better)22.9%
Profitability
Gross margin77.5%88.0% (better)
Operating margin−43.2%−33.4% (better)
Net margin−36.8%−35.7% (better)
FCF margin−21.3% (better)−28.0%
Return on equity−17.3% (better)−48.4%
Return on invested capital−82.9% (better)−136%
Financial health
Debt / equity0.000.96 (better)
Interest coverage−3674.3×−5.4× (better)
Current ratio4.074.95 (better)
Altman Z-score−0.702.15 (better)
Piotroski F-score35 (better)
Dividends and buybacks
Buyback yield−1.00%–
Shareholder yield−1.00%0.00% (better)
Ownership
Held by institutions99.6%40.2%
Held by insiders5.4%33.1%
Insider net buying, 12 months−$118K (better)−$2.2M
Short interest, % of float9.2%3.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.